Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Sweden
/
Lars John Anders Månsson
LJ
Lars John Anders Månsson
Board of Directors, EQL Pharma AB
Bispgatan 71
SE
6 active roles
Watchlist
Share
Overview
Companies & roles
Network
Loading profile…
Companies & roles
Active roles
6 positions
Company
Role
Period
Ownership
Status
EQL Pharma AB
CVR 5567133425
Board
Board of Directors
Since 2020
—
Active
Iconovo AB
CVR 5569380156
Management
Chief Executive Officer
Since 2025
—
Active
Anders Månsson Business Development AB
CVR 5591394878
Board
Board of Directors
Since 2022
—
Active
Immetric AB
CVR 5593317299
Board
Board of Directors
Since 2022
—
Active
Iconovo Pharma AB
CVR 5593430225
Board
Board of Directors
Since 2025
—
Active
PHI MIP AB
CVR 5594355033
Board
Board of Directors
Since 2024
—
Active
Historical roles
5 positions
Company
Role
Period
Ownership
Status
Phase Holographic Imaging PHI AB
CVR 5565427811
Management
Chief Executive Officer
2024 – 2025
—
Active
LIDDS AB
CVR 5565802856
Management
Chief Executive Officer
2022 – 2023
—
Active
Amniotics AB (publ)
CVR 5590246558
Board
Board of Directors
2021 – 2022
—
Dissolved
Chosa Oncology AB
CVR 5590372271
Management
Chief Executive Officer
2020 – 2022
—
Active
LIDDS Pharma AB
CVR 5591489421
Board
Board of Directors
2022 – 2023
—
Active
1 dissolved company in directorship history
Amniotics AB (publ)
CVR 5590246558 · Dissolved 2022 · —
Role: Board of Directors
More on Lars John Anders Månsson
Overview →
Headline figures, risk signals and profile summary
Network →
Connections across other directors and entities